共 42 条
- [31] Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003BLOOD, 2010, 116 (21) : 236 - 236Schradder, Andrevon Stackelberg, ArendSchrappe, MartinKlingebiel, ThomasBader, PeterEbell, WolframHandgretinger, RupertSykora, Karl-WalterSchrum, JohannaKremens, BernhardEhlert, KarolineAlbert, MichaelMeisel, RolandTayfun, GuengoerHolter, WolfgangStrahm, BrigitteGruhn, BerndSchulz, Ansgar S.Zimmermann, MartinPoetschger, UlrikePeters, Christina
- [32] Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors-The ALL-SCT-BFM-2003 TrialJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1265 - +Peters, ChristinaSchrappe, Martinvon Stackelberg, ArendSchrauder, AndreBader, PeterEbell, WolframLang, PeterSykora, Karl-WalterSchrum, JohannaKremens, BernhardEhlert, KarolineAlbert, Michael H.Meisel, RolandMatthes-Martin, SusanneGungor, TayfunHolter, WolfgangStrahm, BrigitteGruhn, BerndSchulz, AnsgarWoessmann, WilhelmPoetschger, UlrikeZimmermann, MartinKlingebiel, Thomas
- [33] Successful unmanipulated stem cell transplantation from HLA-haploidentical 3-loci-mismatched parents in two children with severe aplastic anemia not responding to immunosuppressive therapyAMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (05) : 389 - 390Wang, ZhidongYan, HongminZhu, LingWang, Hengxiang
- [34] Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemiaLEUKEMIA, 2020, 34 (12) : 3359 - 3369Liu, LiminZhang, YanmingJiao, WenjingZhou, HuifenWang, QingyuanJin, SongCai, YifengZhao, LiyunShangguan, XiaohuiLiu, ZefaXu, JingeLei, MeiqingYan, XiaoyunMiao, MiaoWu, Depei
- [35] Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemiaLeukemia, 2020, 34 : 3359 - 3369Limin LiuYanming ZhangWenjing JiaoHuifen ZhouQingyuan WangSong JinYifeng CaiLiyun ZhaoXiaohui ShangguanZefa LiuJinge XuMeiqing LeiXiaoyun YanMiao MiaoDepei Wu
- [36] Inequities in Autologous Stem Cell Transplantation, Chimeric Antigen Receptor T-Cell Therapy and Clinical Trial Participation in Patients Receiving Second-Line and Later Multiple Myeloma TreatmentBLOOD, 2023, 142Pierre, AmyCalip, Gregory S.Ho, GeneGhanim, Majd T.Lu, YichenRyals, Cleo A.Guadamuz, Jenny S.
- [37] Successful Salvage Therapy by Second Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in a Severe Aplastic Anemia Patient Presenting Donor-Specific Anti-HLA Antibodies After Graft Failure From Matched Sibling Donor HSCT: A Case Report and ReviewTRANSPLANTATION PROCEEDINGS, 2021, 53 (04) : 1350 - 1354Si, YejunZhang, XingxiaBian, MeiruLin, GuoqiangWang, LiWang, MiaoZhang, Yanming
- [38] Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions Results from the Second Interim Analysis of the Prospective Azalena-Trial (NCT02472691)BLOOD, 2018, 132Schroeder, Thomas MichaelRautenberg, ChristinaChristopeit, MaxStelljes, MatthiasSchmidt, EvaGroth, ChristophScheid, ChristophHoltick, UdoKlein, Stefan A.Beelen, Dietrich W.Nachtkamp, KathrinHaas, RainerGerming, UlrichKroeger, NicolausKobbe, Guido
- [39] Treatment of relapse of AML and MDS after allogeneic stem cell transplantation using low-dose chemotherapy, donor PBSC and GMCSF: Final results from a prospective, multicenter phase II trial by the German cooperative transplant groupBLOOD, 2007, 110 (11) : 492A - 492ASchmid, ChristophTischer, JohannaSteljes, MatthiasSchleuning, MichaelSchwerdtfeger, RainerHegenbart, UteSchubert, JoergVogel, WichardGruhn, BerdLallinger, ChristianeLedderose, GeorgBornhaeuser, MartinKienast, JoachimKolb, Hans-Jochem
- [40] Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trialLANCET, 2022, 399 (10343): : 2294 - 2308Kamdar, ManaliSolomon, Scott R.Arnason, JonJohnston, Patrick B.Glass, BertramBachanova, VeronikaIbrahimi, SamiMielke, StephanMutsaers, PimHernandez-Ilizaliturri, FranciscoIzutsu, KojiMorschhauser, FranckLunning, MatthewMaloney, David G.Crotta, AlessandroMontheard, SandrinePrevitali, AlessandroStepan, LaraOgasawara, KenMack, TimothyAbramson, Jeremy S.